No Detail Found!

Frequency of TP53 Mutation in B-Cell Chronic Lymphocytic Leukaemia and its Association with Lymphocyte Doubling Time

Author(s)
Syeda Mah Ali Department of Haematology, Liaquat National Hospital,Karachi,Pakistan
Syed Muhammad Irfan Department of Haematology, Liaquat National Hospital,Karachi,Pakistan
Naila Raza Department of Haematology, Liaquat National Hospital,Karachi,Pakistan
Abstract
Objective: To determine the frequency of TP53 mutation at diagnosis of B-cell Chronic Lymphocytic Leukaemia (B-CLL) in Pakistani patients, and to investigate whether lymphocyte doubling time (LDT) of less than 1 year could be used as a surrogate marker forTP53 mutation. Study Design: A cross-sectional descriptive study. Place and Duration of the Study: Department of Haematology, Liaquat National Hospital, from January 2020 to December 2022. Methodology: Patients diagnosed with B-CLL based on the criteria set by International Workshop on Chronic Lymphocytic Leukaemia were included in the study. Clinico-haematological parameters were recorded, andTP53 mutation analysis was performed by uorescence in situ hybridisation. Patients were followed every 3-6 months after diagnosis with the recent complete blood count (CBC) reports to record CBC parameters and calculate LDT. Results: A total of 128 B-CLL cases were evaluated, with a mean age of 62 years. Among these cases, 10 patients (7.8%) tested positive for TP53 mutation, while 118 patients (92.2%) tested negative. During the follow-up period, 26 patients were lost to follow-up, with only one patient from the TP53 positive group. In the TP53 positive group, 55.6% (n=5/9) patients had an LDT of less than 1 year, indicating aggressive disease compared to 30.1% (n=28/93) patients in the negative group (p <0.1). Conclusion: TP53 mutations may be associated with shorter LDT, indicating aggressive disease. Further research is needed to fully comprehend the relationship between TP53 mutation and LDT in B-CLL.
Publication Details
Page(s) 1249-1253
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 33, Issue: 11, Year: 2023

Request the full text from PASTIC

Keywords
TP53 mutation, Lymphocyte doubling time (LDT), B-Cell chronic lymphocytic leukaemia (B-CLL)
0

Citations

0

Downloads

94

Views